93.50
-3.00
(-3.11%)
As of 8:08:21 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | 1 |
| Avg. Estimate | 0 | 0 | 0 | 6.79 |
| Low Estimate | 0 | 0 | 0 | 6.79 |
| High Estimate | 0 | 0 | 0 | 6.79 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 14.94B | 15.91B |
| Low Estimate | -- | -- | 14.94B | 15.91B |
| High Estimate | -- | -- | 14.94B | 15.91B |
| Year Ago Sales | -- | -- | -- | 14.94B |
| Sales Growth (year/est) | -- | -- | -- | 6.50% |
EPS Trend
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 6.79 |
| 7 Days Ago | 0 | 0 | 5.99 | 6.68 |
| 30 Days Ago | 0 | 0 | 5.92 | 6.73 |
| 60 Days Ago | 0 | 0 | 5.85 | 6.59 |
| 90 Days Ago | 0 | 0 | 5.81 | 6.5 |
EPS Revisions
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NEH.BE | -- | -- | -- | -- |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Maintains | Barclays: Equal-Weight to Equal-Weight | 2/24/2025 |
| Maintains | Benchmark: Buy to Buy | 2/21/2025 |
| Maintains | Morgan Stanley: Overweight to Overweight | 2/12/2025 |
| Maintains | B of A Securities: Buy to Buy | 1/15/2025 |
| Upgrade | Morgan Stanley: Equal-Weight to Overweight | 1/8/2025 |
| Maintains | Citigroup: Buy to Buy | 11/15/2024 |